obesity drug news today october 2025 glp-1 The first issue of New Scientist for 2026 brings a sharp focus on to weight loss medications. It suggests that weight-loss medications should get cheaper and more accessible (with expiry of Nutritional priorities to support GLP-1

Initial bone union starts within the first few weeks, but full recovery can take several months

In both animal and early human studies, BPC-157 has shown a strong safety profile

Weight loss program Semaglutide is usually the clearest first GLP-1 choice for people who want a well-studied weekly medication, strong appetite control, and a familiar clinical evidence base

However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)